Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Eli Lilly said in February that it will invest at least $27 billion to build four new manufacturing sites in the U.S. as ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Broadcom, not Nvidia (NASDAQ:NVDA), is currently the top pick among semiconductor investors, according to a new note from Citi analysts following meetings with clients.

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...